Loading...
Lehning
Do not exceed the recommended daily dose, keep out of reach of children.
Information relating to the precautions for use (drug interactions, contraindications, special warnings, adverse effects, etc.) as well as the dosage are detailed in the medicine's leaflet.
Report an adverse effect
Lergypax orodispersible tablets is a medicine used in the adjunctive treatment of certain allergic manifestations such as spasmodic rhinitis, allergic conjunctivitis and hay fever.
C.I.P. reference : 3400921898002
40 unités
Nature de produit : Sublingual tablets Conditionnement : Blister pack Indication / Contre-indication : Dermatologically tested
‹ Return Ask a question ›
Photo non contractuelle - All prices include VAT - excluding delivery costs. Page updated on 18/11/2024
3 october 2024
17 september 2024
> See all news
11 september 2023
1 september 2023
> See all tips